Coloplast A/S (OTCMKTS:CLPBY) Rating Increased to Hold at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) to a hold rating in a research note published on Wednesday,Zacks.com reports.

Coloplast A/S Trading Down 1.1%

Shares of Coloplast A/S stock opened at $8.48 on Wednesday. Coloplast A/S has a 12-month low of $8.34 and a 12-month high of $11.73. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The company has a market cap of $19.11 billion, a price-to-earnings ratio of 35.33, a PEG ratio of 0.82 and a beta of 0.26. The company’s 50-day moving average price is $8.74 and its 200-day moving average price is $9.13.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.10 billion. On average, equities analysts expect that Coloplast A/S will post 0.31 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.